CASI Pharmaceuticals, Inc (DE)

CASIDelisted

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000895051

SEC filings (opens in a new tab)

CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding CASI Pharmaceuticals, Inc (DE) changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of CASI: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	24	23	−1
Shares	1.99M	1.87M	−115.8K (−5.8%)
Value	$5.17M	$3.31M	−$1.86M (−36.0%)

New holders (1)

Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CASI in Q4 2022
Institution	Shares	Value	% of portfolio
Colonial Trust Co	11	$20	0.00%

Sold out (2)

Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CASI in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Prudential Financial Inc	11,000	$29.0K
BNP Paribas Arbitrage, SA	134	$348